Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has now received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kunal Narendra Gandhi Board Meeting-Appointment of Company Secretary / Compliance Officer
Pursuant to Regulation 30 (6) of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements), SEBI (LODR), 2015, we hereby inform that Board of Directors of the Company at its meeting held on 5th April, 2018 has appointed Mr. Dinesh Darji as Company Secretary and Compliance Officer with effect from 6th April, 2018 in the place of Mr. Piyush G Hindia who retired from the services of the Company after closure of working hours of 5th April, 2018.... Board Meeting-Appointment of Director
Pursuant to Regulation 30 (6) of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform that Board of Directors of the Company at its meeting held on 5th April, 2018 appointed Ms. Neha Thakore (DIN 00893957) as Additional Independent Director on the Board of the Company w.e.f 5th April, 2018. Board Meeting-Appointment of Company Secretary / Compliance Officer
Pursuant to Regulation 30 (6) of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements), SEBI (LODR), 2015, we hereby inform that the Board of Directors of the Company at its meeting held on 5th April, 2018 appointed Mr. Dinesh Darji as Company Secretary and Compliance Officer (KMP) of the Company with effect from 6th April, 2018. Announcement under Regulation 30 (LODR)-Retirement
Pursuant to Regulation 30 (6) of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements), SEBI (LODR), 2015, we hereby inform that Board of Directors of the Company at its meeting held on 5th April, 2018 noted and approved retirement of Shri. P. G. Hindia as Company Secretary and Compliance Officer (KMP) of the Company after the closing hours of the Company w.e.f 5th April, 2018 and he has been relieved as Company Secretary and Compliance Officer of the Company. Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Lyka Labs Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here NCLT Convened Meeting Held On 27Th March, 2018
Voting Results and Scrutinizer Report of NCLT Convened Shareholders Meeting on 27th March, 2018 for merger of Lyka Healthcare Limited (Wholly Owned Subsidiary) with Lyka Labs Limited which was passed with requisite majority. (Voting Results and Scrutinizer Report is attached) Proceeding Of NCLT Convened Shareholders Meeting, Preference Shareholder Meeting, Secured Creditor Meeting And Unsecured Creditor Meeting
Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we forward herewith proceedings of NCLT Convened Meetings of Equity Shareholders, Preference Shareholder, Secured Creditors and Unsecured Creditors of the Company held on 27th March, 2018 at our Registered Office of the Company i.e. 4801/B & 4802/A, GIDC, Industrial Estate, Ankleshwar- 393002. NCLT Convened Meeting On 27Th March, 2018
The Company has convened meeting of Equity Shareholders, Preference Shareholders, Secured creditors and Un-secured creditors on 27th March, 2018 at its registered office at Ankleshwar, as per NCLT order dated 6th February, 2018 for seeking their consent to the proposed merger of Lyka Healthcare Limited, wholly owned subsidiary with Lyka Labs Limited. The respective notices issued to above parties and copy of NCLT order are attached for your information. Announcement under Regulation 30 (LODR)-Allotment
We wish to inform you that the Board of Directors at their meeting held today has allotted 550000 Equity Warrants on Preferential basis at a price of Rs.55/- each to Enai Trading & Investment Pvt. Ltd.